MALLINCKRODT MEDICAL INC -- HIPPURAN I 131 INJECTION -- 6505-00F035477
=====================  Product Identification  =====================

Product ID:HIPPURAN I 131 INJECTION
MSDS Date:01/01/1995
FSC:6505
NIIN:00F035477
=== Responsible Party ===
Company Name:MALLINCKRODT MEDICAL INC
Address:2703 WAGNER PLACE
City:MARYLAND HEIGHTS
State:MO
ZIP:63043-3421
Country:US
Info Phone Num:314-770-7800/314-895-2000
Emergency Phone Num:314-770-7800
CAGE:FO650
=== Contractor Identification ===
Company Name:MALLINCKRODT DIAGNOSTICS
Address:2703 WAGNER PLACE
Box:City:MARYLAND HEIGHTS
State:MO
ZIP:63043-3421
Country:US
Phone:314-344-3800
CAGE:2A916
Company Name:MALLINCKRODT MEDICAL INC
Address:2703 WAGNER PLACE
City:MARYLAND HEIGHTS
State:MO
ZIP:63043-3421
Country:US
Phone:314-770-7800/314-895-2000
CAGE:FO650

=============  Composition/Information on Ingredients  =============

Ingred Name:HIPPURAN I 131
CAS:881-17-4
Fraction by Wt: <1%

Ingred Name:DISODIUM EDETATE; ACETIC ACID, (ETHYLENEDINITRILO)TETRA-,
    DISODIUM SALT; EDTA DISODIUM
CAS:139-33-3
RTECS #:AH4375000
Fraction by Wt: 0.005%

Ingred Name:SODIUM CITRATE, TRISODIUM SALT, CITRIC ACID
CAS:68-04-2
RTECS #:GE8300000
Fraction by Wt: 0.02%

Ingred Name:BENZOIC ACID, 4-HYDROXY-, PROPYL ESTER, PROPYLPARABEN
CAS:94-13-3
RTECS #:DH2800000
Fraction by Wt: 0.03%

Ingred Name:METHYL PARAHYDROXYBENZOATE, METHYLPARABEN
CAS:99-76-3
RTECS #:DH2450000
Fraction by Wt: 0.1%

Ingred Name:1,2-PROPANEDIOL (PROPYLENE GLYCOL)
CAS:57-55-6
RTECS #:TY2000000
Fraction by Wt: 37.5%

=====================  Hazards Identification  =====================

Routes of Entry: Inhalation:NO	Skin:NO  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:RADIOACTIVE MATERIAL. SKIN:
    IRRITATION. EYES: MECHANICAL IRRITATION. INGESTION: ASYMPTOMATIC
    PHYSIOLOGICAL UPTAKE BY THYROID GLAND/OTHER TISSUES. UPTAKE OF
    I-131 BY THYROID GLAND CAN RESULT IN SLIGHT  TO TOTAL THYROID
    DYSFUNCTION. CHRONIC RADIATION EXPOSURE MAY CAUSE CANCER, LEUKEMIA,
    GENETIC & TERATOGENIC EFFECTS.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION.

=======================  First Aid Measures  =======================

First Aid:NOTIFY RADIATION SAFETY PERSONNEL IMMEDIATELY. INHALATION:
    ASSESS/DOCUMENT AMOUNT OF MATERIAL. INGESTION: ASSESS/DOCUMENT
    AMOUNT OF I-131 IN THYROID GLAND. THYROID BLOCKING AGENT MAY BE
    WARRANTED. SKI N: WASH AFFECTED AREA THOROUGHLY W/SOAP& WATER.
    ALWAYS BLOT DRY. DON'T ABRADE SKIN. EYES: FLUSH W/WATER FOR 15
    MINS/UNTIL NO MORE RADIOACTIVITY CAN BE REMOVED. OBTAIN MEDICAL
    ATTENTION IN ALL CASES.

=====================  Fire Fighting Measures  =====================

Flash Point:NON-FLAMMABLE
Extinguishing Media:USE MEDIA APPROPRIATE FOR SURROUNDING FIRE.
Fire Fighting Procedures:WEAR A NIOSH APPROVED SELF-CONTAINED BREATHING
    APPARATUS W/FULL FACEPIECE OPERATED IN PRESSURE DEMAND/OTHER
    POSITIVE PRESSURE MODE & FULL PROTECTIVE CLOTHING.

==================  Accidental Release Measures  ==================

Spill Release Procedures:IF PRODUCT IS RECEIVED IN A LEAKING
    CONDITION/ANY LOSS/RELEASE OF RADIOACTIVE CONTENTS OCCURS, NOTIFY
    YOUR RADIATION SAFETY DEPARTMENT & MALLINCKRODT @ 314-770-7800.
    (SEE SUPP)

======================	Handling and Storage  ======================

Handling and Storage Precautions:STORE BETWEEN 59-86F. KEEP HANDLING
    TIME TO MINIMUM & USE APPROPRIATE SHIELDING. USE SYRINGE SHIELDS &
    TONGS WHEN HANDLING.
Other Precautions:STORAGE & DISPOSAL OF PRODUCT SHOULD BE CONTROLLED
    IAW/APPROPRIATE REGULATIONS OF FEDERAL/STATE GOVERNMENT AGENCY
    AUTHORIZED TO LICENSE USE OF THIS RADIONUCLIDE. DON'T SMOKE,
    EAT/DRINK WHERE RADIOACTI VE MATERIALS ARE HANDLED/STORED.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:NOT EXPECTED TO REQUIRE USE OF PERSONAL
    RESPIRATOR.
Ventilation:PROPERLY SEALED CONTAINERS AREN'T EXPECTED TO REQUIRE ANY
    SPECIAL VENTILATION.
Protective Gloves:DISPOSABLE PLASTIC, LATEX, RUBBER
Eye Protection:SAFETY GLASSES.
Other Protective Equipment:DISPOSABLE LABCOAT
Supplemental Safety and Health
SPILL PROCEDURES: ALL CLEANUP OPERATIONS SHOULD BE PERFORMED
    IAW/STANDARD OPERATING PROCEDURES, NRC/OTHER APPLICABLE FEDERAL,
    STATE & LOCAL REGULATIONS. WASTE DISPOSAL: WASTE HIPPURAN I 131 IS
    NON-HAZ ARDOUS IF NOT RADIOACTIVE/A BIOHAZARD. RADIOACTIVE MATERIAL
    UN 2982.

==================  Physical/Chemical Properties  ==================

Boiling Pt:B.P. Text:212F
Melt/Freeze Pt:M.P/F.P Text:32F
Solubility in Water:COMPLETE
Appearance and Odor:CLEAR, COLORLESS LIQUID IN A 10 ML GLASS VIAL W/NO
    ODOR.

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
Hazardous Decomposition Products:HEATED TO DECOMPOSITION: RADIOACTIVE
    FUMES CONTAINING I-131.

====================  Disposal Considerations  ====================

Waste Disposal Methods:HIPPURAN I 131 IS RADIOACTIVE WASTE UNTIL
    ACTIVITY HAS DECAYED TO NONDETECTABLE LEVELS. RADIOACTIVE WASTE
    MUST BE HANDLED IAW/NRC, FEDERAL, STATE & LOCAL REGULATIONS.
    MEDICAL WASTE, BLOOD, BLOOD PRODU CTS/SHARPS MUST BE HANDLED AS
    BIOHAZARD. (SUPP)

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.